Clinical trials of lasers for toenail onychomycosis: The implications of new regulatory guidance

References

• de Sá DC, Lamas APB, Tosti A. Oral therapy for onychomycosis: an evidence-based review. Am J Clin Dermatol. 2014;15:17–36.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Daigle D, Foley KA. Topical therapy for toenail onychomycosis: an evidence-based review. Am J Clin Dermatol. 2014;15:489–502.
   PubMed Web of Science ®Google Scholar
• Bristow IR. The effectiveness of lasers in the treatment of onychomycosis: a systematic review. J Foot Ankle Res. 2014;7:34.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Simpson F. Newly approved laser systems for onychomycosis. J Am Podiatr Med Assoc. 2012;102:428–30.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Medical Devices and Clinical Trial Design for the Treatment or Improvement in the Appearance of Fungally-Infected Nails – Draft Guidance for Industry and FDA Staff [Internet]. 2015 [cited 2015 May 22]; Available from http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM431312.pdf.
   Google Scholar
• Novartis. LAMISIL (terbinafine hydrochloride) Tablets, 250 mg [Internet]. [cited 2013 Mar 15]; Available from http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020539s021lbl.pdf.
   Google Scholar
• Valeant Pharmaceuticals. JUBLIA® (efinaconazole) topical solution, 10% [Internet]. [cited 2014 Sep 17]; Available from http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203567s000lbl.pdf.
   Google Scholar
• Elewski BE, Rich P, Pollak R, et al. Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68:600?8.
   Web of Science ®Google Scholar
• Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. BMJ. 1999;318:1031–5.
   PubMed Web of Science ®Google Scholar
• Pinpointe USA. 510(k) Summary K093547. PinPointe FootLaser, Pinpointe USA Inc. [Internet]. 2010 [cited 2011 Oct 24]; Available from http://www.accessdata.fda.gov/cdrh_docs/pdf9/K093547.pdf.
   Google Scholar
• Gupta AK, Ryder JE, Bluhm R, et al. Onychomycosis: quality of studies. J Cutan Med Surg. 2003;7:312–16.
   PubMed Web of Science ®Google Scholar
• Landsman AS, Robbins AH, Angelini PF, et al. Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure. J Am Podiatr Med Assoc. 2010;100:166–77.
   PubMed Web of Science ®Google Scholar
• Ortiz AE, Truong S, Serowka K, Kelly KM. A 1,320-nm Nd: YAG laser for improving the appearance of onychomycosis. Dermatol Surg Off Publ Am Soc Dermatol Surg. 2014;40:1356–60.
   PubMed Web of Science ®Google Scholar
• Harris DM, McDowell BA, Strisower J. Laser treatment for toenail fungus. Proc SPIE. 2009;7161:71610M1–7.
   Google Scholar
• Hollmig ST, Rahman Z, Henderson MT, et al. Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized, controlled trial. J Am Acad Dermatol. 2014;70:911–7.
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang D, Zhuo F, et al. Long-pulse Nd:YAG 1064-nm laser treatment for onychomycosis. Chin Med J (Engl.). 2012;125:3288–91.
   PubMed Web of Science ®Google Scholar
• Elewski B, Pollak R, Ashton S, et al. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis. Br J Dermatol. 2012;166:389–98.
   PubMed Web of Science ®Google Scholar
• Elewski BE, Aly R, Baldwin SL, et al. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies. J Am Acad Dermatol. 2015;73:62–9.
   PubMed Web of Science ®Google Scholar
• Galvan Garcia HR. Onychomycosis: 1064-nm Nd:YAG q-switch laser treatment. J Cosmet Dermatol. 2014;13:232–5.
   PubMed Web of Science ®Google Scholar
• Hees H, Jäger MW, Raulin C. Treatment of onychomycosis using the 1 064 nm Nd:YAG laser: a clinical pilot study. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2014;12:322–9.
   PubMed Web of Science ®Google Scholar
• Carney C, Cantrell W, Warner J, Elewski B. Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser. J Am Acad Dermatol. 2013;69:578–82.
   PubMed Web of Science ®Google Scholar
• El-Tatawy RA, Abd El-Naby NM, El-Hawary EE, Talaat RAZ. A comparative clinical and mycological study of Nd-YAG laser versus topical terbinafine in the treatment of onychomycosis. J. Dermatol Treat. 2015;26:461–4.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Paquet M. A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis. J Dermatol Treat. 2015;26:376–8.
   PubMed Web of Science ®Google Scholar
• Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmet Laser Ther. 2011;13:2–5.
   PubMed Web of Science ®Google Scholar
• Kalokasidis K, Onder M, Trakatelli M-G, et al. The effect of Q-switched Nd:YAG 1064 nm/532 nm laser in the treatment of onychomycosis in vivo. Dermatol Res Pract. 2013;2013:379725. doi: 10.1155/2013/379725.
   PubMedGoogle Scholar
• Kimura U, Takeuchi K, Kinoshita A, et al. Treating onychomycoses of the toenail: clinical efficacy of the sub-millisecond 1,064 nm Nd: YAG laser using a 5 mm spot diameter. J Drugs Dermatol JDD. 2012;11:496–504.
   PubMed Web of Science ®Google Scholar
• Kozarev J, Vižintin Z. Novel laser therapy in treatment of onychomycosis. J Laser Health Acad. 2010;2010:1–8.
   Google Scholar
• Li Y, Yu S, Xu J, et al. Comparison of the efficacy of long-pulsed Nd:YAG laser intervention for treatment of onychomycosis of toenails or fingernails. J Drugs Dermatol. 2014;13:1258–63.
   PubMed Web of Science ®Google Scholar
• Lim E-H, Kim H-R, Park Y-O, et al. Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. J Am Acad Dermatol. 2014;70:918–23.
   PubMed Web of Science ®Google Scholar
• Moon SH, Hur H, Oh YJ, et al. Treatment of onychomycosis with a 1,064-nm long-pulsed Nd:YAG laser. J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol. 2014;16:165–70.
   PubMed Web of Science ®Google Scholar
• Noguchi H, Miyata K, Sugita T, et al. Treatment of onychomycosis using a 1064nm Nd:YAG laser. Med Mycol J. 2013;54:333–9.
   PubMedGoogle Scholar
• Renner R, Grüsser K, Sticherling M. 1,064-nm diode laser therapy of onychomycosis: results of a prospective open treatment of 82 toenails. Dermatology (Basel). 2015;230:128–34.
   PubMed Web of Science ®Google Scholar
• Sullivan R, O’Flynn D. Erchonia laser therapy in the treatment of onychomycosis: a preliminary report on an ongoing clinical trial. Podiatry Rev. 2014;71:6–9.
   Google Scholar
• Waibel J, Rudnick A, Wulkan AJ. Prospective efficacy and safety evaluation of laser treatments with real-time temperature feedback for fungal onychomycosis. J Drugs Dermatol. 2013;12:1237.
   PubMed Web of Science ®Google Scholar
• Wanitphakdeedecha R, Thanomkitti K, Bunyaratavej S, Manuskiatti W. Efficacy and safety of 1064-nm Nd:YAG laser in treatment of onychomycosis. J Dermatol Treat. 2016;27:75–9.
   PubMed Web of Science ®Google Scholar
• Weiss D. 3 Month Clinical Results using Sub-millisecond 1064 nm Nd:YAG Laser for the Treatment of Onychomycosis [Internet]. 2011; Available from http://conejofeet.com/wp-content/uploads/2011/06/David-Weiss-DPM-report.pdf.
   Google Scholar
• Xu Y, Miao X, Zhou B, Luo D. Combined oral terbinafine and long-pulsed 1,064-nm Nd: YAG laser treatment is more effective for onychomycosis than either treatment alone. Dermatol Surg. 2014;40:1201–7.
   PubMed Web of Science ®Google Scholar